[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368870-105":59,"doc-detail-368870-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","interstitial-lung-disease-epidemiology-and-etiology-in-patients-with-solid-malignant-tumors-a-systematic-literature-review","Interstitial lung disease epidemiology and etiology in patients with solid malignant tumors - a systematic literature review","","Interstitial lung disease (ILD) occurs in patients with cancer and may arise from anticancer treatments (drug-induced ILD) or from other causes, including opportunistic infection and non-drug-related etiologies. This systematic literature review (SLR) examined epidemiology and etiology of non-drug-induced ILD, along with ILD management and outcomes in patients with solid cancers. Searches through August 2023 yielded 55 included studies, with most evidence focused on drug-induced ILD and limited non-DI reporting.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/interstitial-lung-disease-epidemiology-and-etiology-in-patients-with-solid-malignant-tumors-a-systematic-literature-review/368870/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/interstitial-lung-disease-epidemiology-and-etiology-in-patients-with-solid-malignant-tumors-a-systematic-literature-review/368870.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the systematic literature review address?","Question",{"text":112,"@type":113},"The review investigates how common non-drug-induced ILD and drug-induced ILD are in patients with solid cancers, and what causes and outcomes are reported. It also summarizes how ILD is managed in this population.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was evidence gathered in the review?",{"text":117,"@type":113},"Databases were searched through August 2023 using terms for ILD and solid cancers. Relevant congresses from 2021–2023 and SLR bibliographies were also hand-searched, and screening used two independent reviewers.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the review find about non-drug-induced ILD evidence?",{"text":121,"@type":113},"Evidence for non-drug-induced ILD was limited and reported only in relation to radiation therapy or surgery. Most included studies reported outcomes for drug-induced ILD.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368870,1790199276,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","FUTURE ONCOLOGY  \n2025, VOL. 21, NO. 23, 3063–3073  \n[https://doi.org/10.1080/14796694.2025.2550928](https://doi.org/10.1080/14796694.2025.2550928)  \nSYSTEMATIC REVIEW     \nInterstitial lung disease epidemiology and etiology in patients with solid malignant tumors: a systematic literature review  \nEgbert F. Smit a, Simon M. Collin b, Manoj Prahladanb, Flavia Lujan b, Emma Drane c, Emily Kaiser d, Ambar Khan e and Pierfranco Conte f  \naDepartment of Pulmonary Diseases, Leiden University Medical Center, Leiden, The Netherlands; bOncology Outcomes Research (O2R), Evidence Generation, Publications, and Partnerships, Global Medical Affairs, Oncology Business Unit, AstraZeneca, Cambridge, UK; cEvidence Development, Costello Medical, Cambridge, UK; dEvidence Development, Costello Medical, Boston, MA, USA; e Evidence Development, Costello Medical, London, UK; fDivision of Oncology, San Camillo Hospital IRCCS, Lido di Venezia, Venezia, Italy  \nABSTRACT  \nBackground: Interstitial lung disease (ILD) can occur in patients with cancer. ILD can be caused by anticancer treatments (drug-induced [DI] ILD), but also by opportunistic infection, and non-drug-related etiologies. This systematic literature review (SLR) investigated the epidemiology and etiology of non-DI ILD and DI ILD management and outcomes in patients with solid cancers.  \nMethods: Databases were searched to August 2023 using terms for ILD and solid cancers. Relevant congresses held 2021–2023 and SLR bibliographies were hand-searched. Records were screened by two independent reviewers. Inclusion criteria comprised ILD epidemiology outcomes, ILD clinical management, and survival outcomes.  \nResults: Of 4,519 unique records screened, 55 full texts were included (six from supplementary sources) and 37 were prioritized for extraction. Studies were frequently retrospective cohort studies in Japan (n = 21). Patients mostly had lung cancers (n = 32) and received immune checkpoint inhibitors (n = 24). Reporting of non-DI ILD was limited and associated with radiation therapy (n = 4) or surgery (n = 1). Most studies reported DI ILD outcomes only (n = 31).  \nConclusion: The limited evidence of non-DI ILD indicates that prompt intervention to manage ILD until other ILD etiologies have been ruled out remains key to preventing progression of both cancer and ILD. Protocol registration [http://www.crd.york.ac.uk/prospero](http://www.crd.york.ac.uk/prospero) identifier: CRD42023463573.  \nPLAIN LANGUAGE SUMMARY  \nInterstitial lung disease, or “ILD,” is a group of conditions that cause scarring and swelling in the lungs. This makes it harder to breathe and get enough oxygen. New cancer drugs can work well to treat a person’s cancer, but they can sometimes cause ILD as a side-effect (known as “drug-induced” ILD) . ILD can have other causes unrelated to cancer treatment. For example, some lung infections can cause ILD. When ILD occurs, a person’s cancer treatment has to be paused until the lung condition improves, which could worsen outcomes.  \nWe aimed to find out how commonly these other causes of ILD occur in people with solid cancers (cancers that affect tissues and organs such as breast, lung, and liver) and what these causes are. We also looked at survival outcomes in patients who develop ILD and how ILD is treated.  \nWe identified 55 published studies, mostly from Japan and in people with lung cancer. ILD not caused by cancer treatment was rarely reported and was linked to radiation therapy or surgery in all of the studies that we reviewed. No cases of ILD caused by infection were found in these studies, even though some known cases have been reported in medical case reports. We found that people had shorter survival times on average if they had severe ILD or if the ILD developed soon after starting cancer treatment. Although we did not find many studies reporting other causes of ILD in people with cancer, it is still very important that doctors follow guidelines closely to find out whether t","cbCaivPgNxslrtNo","https://ap.wps.com/l/cbCaivPgNxslrtNo","pdf",2439457,11,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Plain language summary\n# Article highlights","[{\"question\":\"What question does the systematic literature review address?\",\"answer\":\"The review investigates how common non-drug-induced ILD and drug-induced ILD are in patients with solid cancers, and what causes and outcomes are reported. It also summarizes how ILD is managed in this population.\"},{\"question\":\"How was evidence gathered in the review?\",\"answer\":\"Databases were searched through August 2023 using terms for ILD and solid cancers. Relevant congresses from 2021–2023 and SLR bibliographies were also hand-searched, and screening used two independent reviewers.\"},{\"question\":\"What did the review find about non-drug-induced ILD evidence?\",\"answer\":\"Evidence for non-drug-induced ILD was limited and reported only in relation to radiation therapy or surgery. Most included studies reported outcomes for drug-induced ILD.\"}]","Interstitial lung disease epidemiology and etiology in patients with solid malignant tumors - a systematic literature review | PDF",1790179017,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52be8de586e9b68f94fe2c576ab859c7.webp",983,1280,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5aefedfc9d87a79438b55a124f90d3a1.webp",982,1278,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53c7130b34d27851a479ebb53ba8b753.webp",981,1277,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dccd884c4825e44df4efb4cd9a07a3ba.webp",980,1276]